1800-272-662
Shopping Cart 0
countryflagAU
Login

Enlitic Inc

Healthcare AU ENL

0.007AUD
-(-%)

Last update at 2026-03-13T05:14:00Z

Day Range

0.0060.007
LowHigh

52 Week Range

0.0060.08
LowHigh

Fundamentals

  • Previous Close 0.007
  • Market Cap5.00M
  • Volume5889436
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-12.70718M
  • Revenue TTM3.80M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM -8.42223M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax -13.34219M -15.25025M -15.55144M -25.04082M
Minority interest - - - -
Net income -13.37382M -15.23790M -15.55144M -25.04082M
Selling general administrative 12.17M 15.50M 14.39M 16.13M
Selling and marketing expenses - - - -
Gross profit 3.80M 1.08M 0.50M -
Reconciled depreciation 0.67M 0.16M 0.40M -
Ebit - - - -
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -13.35019M -15.74450M -15.49574M -17.56079M
Other operating expenses - - - -
Interest expense 0.04M 0.00023M 0.05M -
Tax provision 0.03M -0.01236M 0.00000M 0.00000M
Interest income 0.04M 0.01M 0.06M 7.48M
Net interest income -0.00318M 0.12M 0.00574M -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 3.80M 1.22M 0.56M 0.90M
Total operating expenses - - - -
Cost of revenue - - - -
Total other income expense net 0.01M 0.52M -0.05253M -
Discontinued operations - - - -
Net income from continuing ops -13.37382M -15.23789M -15.55144M -
Net income applicable to common shares - -15.23790M -15.55144M -25.04082M
Preferred stock and other adjustments - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 8.96M 14.20M 11.57M 3.10M
Intangible assets 2.90M 0.02M 0.00717M 0.01M
Earning assets - - - -
Other current assets 0.08M 0.15M 0.01M -
Total liab 4.88M 3.17M 0.63M 30.76M
Total stockholder equity 4.08M 11.03M 10.94M -27.66436M
Deferred long term liab - - - -
Other current liab 2.02M 1.09M - -
Common stock - - - 58.76M
Capital stock 134.50M 128.17M 112.75M -
Retained earnings -133.74231M -120.36849M -105.13059M -86.63870M
Other liab - - - -
Good will 1.84M 4.33M - -
Other assets - - - -
Cash 2.57M 7.16M 11.09M 2.22M
Cash and equivalents - - - -
Total current liabilities 4.88M 2.90M 0.63M 30.76M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - 23.93M
Short long term debt 0.89M - - -
Short long term debt total - - - -
Other stockholder equity - - - 0.21M
Property plant equipment - - - 0.51M
Total current assets 4.08M 8.69M 11.44M 2.57M
Long term investments - - - -
Net tangible assets - - - -
Short term investments - - - -
Net receivables 0.84M 0.67M 0.07M 0.04M
Long term debt - 0.20M - -
Inventory - - - -
Accounts payable 0.46M 1.18M 0.26M -
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - 0.00277M - -
Deferred long term asset charges - - - -
Non current assets total 4.87M 5.51M 0.13M -
Capital lease obligations 0.00513M 0.11M - -
Long term debt total - - - 0.00000M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Investments - -3.11993M 0.00055M -
Change to liabilities - - - -
Total cashflows from investing activities - -3.11993M - -
Net borrowings 1.49M - - -
Total cash from financing activities 7.71M 14.45M 23.72M -
Change to operating activities - - - -
Net income -13.37382M -15.23789M -15.55144M -25.04082M
Change in cash -4.06294M -3.93435M 8.84M -
Begin period cash flow 7.16M 11.09M 2.22M -
End period cash flow 2.57M 7.16M 11.09M 2.22M
Total cash from operating activities - -15.16621M - -
Issuance of capital stock 6.92M 15.61M 25.38M -
Depreciation - - - -
Other cashflows from investing activities - -0.00375M - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables - - - -
Sale purchase of stock -0.58656M -1.13708M -1.35505M -
Other cashflows from financing activities - -0.02314M - -
Change to netincome - - - -
Capital expenditures 0.01M 0.02M 0.00458M 0.00000M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - 0.12M - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow -11.80373M -15.18713M -14.88476M -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ENL
Enlitic Inc		 - -% 0.007 - - 1.32 1.02 0.65 -2.3749
PME
Pro Medicus Ltd		 -0.55 0.41% 133.00 59.62 73.53 58.00 36.74 58.50 75.61
AYA
ARTRYA Ltd		 -0.17 5.04% 3.20 - - 17488.26 5.98 5516.69 0.33
EIQ
Echoiq Ltd		 0.02 2.94% 0.70 - - 5046.68 25.81 4779.15 -8.2701
CGS
Cogstate Ltd		 -0.02 0.92% 2.15 23.89 19.96 6.58 5.14 4.32 13.45

Reports Covered

Stock Research & News

View All

Profile

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.

Enlitic Inc

1635 Foxtrail Drive, Loveland, CO, United States, 80538

Key Executives

Name Title Year Born
Mr. Lawrence B. Gozlan B.Sc., B.Sc.(Hons) Executive Chairman of the Board 1979
Mr. Michael Karlgerhard Sistenich B.Sc, M.Sc., MSc CEO & Director 1975
Mr. Kevin Lyman Founder & Chief Science Officer NA
Mr. Darren Scotti Chief Financial Officer NA
Mr. John Marshall Chief Operating Officer NA
Mr. Dan Kozimor Chief Technology Officer NA
Ms. Patty O'Brien Chief Compliance Officer NA
Mr. Dave Wilson Vice President of Marketing & Communications NA
Mr. Scott Stanton Vice President of Sales Operations NA
Mr. Ryan Lennartson Vice President of People Operations NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.